Limitless X Holdings LIMX
OTC LIMX
$0.60 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Limitless X Holdings (LIMX) Income from Discontinued Operations (2023)

Limitless X Holdings' (LIMX) quarterly Income from Discontinued Operations came in at $3708.0 in Q4 2023, up 108.58% quarter-over-quarter from -$43201.0 in Q3 2023.

Analysis

Limitless X Holdings (LIMX) Income from Discontinued Operations (2023) Analysis & Trends

Limitless X Holdings has disclosed Income from Discontinued Operations across 1 years of filings, most recently posting $3708.0 for Q4 2023.

  • In Q4 2023, Income from Discontinued Operations changed N/A year-over-year to $3708.0; the TTM figure through Dec 2023 stood at -$41347.0 (changed N/A YoY), while the FY2023 annual figure was $1854.0, changed N/A from the prior year.
  • Income from Discontinued Operations came in at $3708.0 for Q4 2023 at Limitless X Holdings, up from -$43201.0 in the prior quarter.
  • In the past five years, Income from Discontinued Operations ranged from a high of $3708.0 in Q4 2023 to a low of -$43201.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Colgate Palmolive 70.27 Bn 68.90 Bn 3.30 Bn -
2 Kenvue 34.17 Bn 33.06 Bn 2.30 Bn -
3 Kimberly Clark 32.86 Bn 31.91 Bn 1.60 Bn -60.00 Mn
4 Bath & Body Works 3.85 Bn 3.05 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.32 Bn 2.26 Bn - -
6 Perrigo 1.99 Bn 1.59 Bn 313.90 Mn -14.10 Mn
7 Herbalife 1.32 Bn 946.20 Mn 1.03 Bn -
8 Edgewell Personal Care 1.24 Bn 842.99 Mn 242.50 Mn 1.40 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Limitless X Holdings 11.84 Mn 11.84 Mn 30,160.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3,708.00
Sep 30, 2023 -43,201.00
Jun 30, 2023 -515.00
Mar 31, 2023 -1,339.00